Navigation Links
Drug shown to reverse radioiodine resistance in some advanced thyroid cancers
Date:2/13/2013

NRAS gene mutation, selumetinib increased iodine uptake enough to allow patients to undergo RAI therapy.

Following RAI, five patients had confirmed partial responses and three had stable disease. In seven of the eight patients, outcomes remained unchanged during six months of follow-up. All eight patients had a decreased level of serum thyroglobulin a protein in the blood used to screen for advanced thyroid cancer and none experienced serious side effects from selumetinib.

"An advantage of this therapeutic strategy is that only a short course of drug therapy is required to elicit a significant clinical effect," Fagin said, adding that "the initial results show promise for RAS-mutant disease, but the hope is that a larger trial will shed light on whether selumetinib can be effective for a broader range of advanced thyroid cancer subtypes."

Memorial Sloan-Kettering will lead the international, multicenter phase III clinical trial of selumetinib later this year. The trial, which will be sponsored by AstraZeneca, will enroll patients who have recently had their thyroid gland removed a procedure known as total thyroidectomy due to thyroid cancer that has spread to nearby tissue or lymph nodes.


'/>"/>

Contact: Caitlin Hool
HOOLC@MSKCC.ORG
212-639-3573
Memorial Sloan-Kettering Cancer Center
Source:Eurekalert

Page: 1 2

Related biology news :

1. Community-based nutrition education shown to be successful in increasing calcium intake
2. Compounds shown to thwart stubborn pathogens social propensity
3. Antioxidant shown to reduce blindness risk in extremely premature babies
4. Vitamin D with calcium shown to reduce mortality in elderly
5. Gallbladder shown as potential stem cell source for regenerative liver and metabolic disease
6. Pycnogenol (French maritime pine bark extract) shown to improve menopause symptoms in new study
7. Promising compound restores memory loss and reverses symptoms of Alzheimers
8. Scripps Florida scientists design molecule that reverses some fragile X syndrome defects
9. BUSM researchers find potential key to halt progression, reverse damage from emphysema
10. Medusa reimagined: Caltech-led team reverse engineers a jellyfish with the ability to swim
11. Drug could reverse scourge of cerebral malaria for survivors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2014)... VIEW, Calif. , Dec. 4, 2014 /PRNewswire/ ... safety has boosted investments in new testing and ... has also given rise to a range of ... by the requirements of Generation Y, which is ... technologies. As a result, product development strategies of ...
(Date:12/3/2014)... 2, 2014 As part of our commitment ... is pleased to announce the release of a new ... collect the workforce data that they need. ... left by existing readers. Many such devices have serious ... modern technology. Older models force users to navigate numerous ...
(Date:11/21/2014)... -- C-Labs LLC, a leading provider of remote and ... announced the appointment of John Traynor to ... advisor to the firm, Mr. Traynor will now oversee ... out of the C-Labs office in Redmond, ... , Chief Executive Officer. Photo - ...
Breaking Biology News(10 mins):Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Inception Technologies to Release New Biometric Reader 2C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2
... Medical Biology (IMB) scientists under the Agency of Science, ... an international team of researchers [1]who became the first ... rare skin cancer which grows rapidly for a few ... Nature Genetics [2] today. The peculiar ...
... requires an increasingly interdisciplinary perspective. Presenters at the National ... 2 will discuss ways to identify, encourage, and support ... in this and other fields. In ... the 11th annual Sackler Lecture beginning at 6 p.m. ...
... neurosurgery to bar code readers, lasers have been used in ... the late 1950,s. Now, with the work being done in ... way to use lasers to study the splicing of pre-messenger ... advanced organisms, including human life. This process of splicing is ...
Cached Biology News:Scientists discover cause of rare skin cancer that heals itself 2Brandeis researchers use lasers, custom microscope to show gene splicing process in real time 2Brandeis researchers use lasers, custom microscope to show gene splicing process in real time 3
(Date:12/24/2014)... and NEW YORK , ... PTBI, PTBIW), a biopharmaceutical company advancing patient care in ... offering of 3,500,000 shares of common stock, and warrants ... common stock, at an offering price of $4.00 per ... per share exercise price of $5.00, are exercisable immediately, ...
(Date:12/24/2014)... Earlier this year in a June 24 international ... Adult Stem Cell Technology Center, LLC ( ASCTC ) ... unique property of adult tissue stem cells. His ... the Past, Important for the Future,” embodied the essence ... the address at the 4th World Congress on Cell ...
(Date:12/24/2014)... Nashville Fertility Center announced that Dr. George ... Society for Reproductive Medicine (ASRM), a leading professional organization ... In his new role as treasurer, Dr. Hill ... will have a voice in furthering the mission of ... since 1984 when he joined while conducting fellowship training ...
(Date:12/24/2014)... PharmaBoardroom,s new report, , Healthcare and ... free download , digs deep into this vibrant market, ... sector today. One area where Algeria ... a homegrown pharmaceutical manufacturing base, even if the government,s ambitious ... off. A cursory comparison with neighboring Morocco ...
Breaking Biology Technology:PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 3PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3
... Second Quarter and Six-Month Results -- NEW YORK, Aug. 19 /PRNewswire-Asia/ -- ... ... ... var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
... and CAMBRIDGE, Massachusetts, August 19, 2010, ... ... var shortURL ... by longUrl, so we need to grab the first one. for (var r in data.results) { ...
... an improved coating technique that could strengthen the connection ... The stronger connection -- created by manipulating signals the ... allow the implants to last longer. Implants coated ... mimics the body,s own cell-adhesion material fibronectin made 50 ...
Cached Biology Technology:Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 2Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 3Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 4Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 5Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 6Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 7Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 8Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 9Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 10Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 11Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 12Broad Institute Acquires License to all ChemAxon products and Deploys Across Chemical Biology Platform 2Broad Institute Acquires License to all ChemAxon products and Deploys Across Chemical Biology Platform 3Broad Institute Acquires License to all ChemAxon products and Deploys Across Chemical Biology Platform 4Broad Institute Acquires License to all ChemAxon products and Deploys Across Chemical Biology Platform 5Broad Institute Acquires License to all ChemAxon products and Deploys Across Chemical Biology Platform 6Titanium coating with protein 'flower bouquet' nanoclusters strengthens implant attachment 2Titanium coating with protein 'flower bouquet' nanoclusters strengthens implant attachment 3
... years of expertise in the field of ... the most powerful systems on the market. ... 000 in-microplate tests requiring incubation and washing ... modules (such as worktable shaker incubators, reader,washer), ...
... pre-validated SNP sequencing services ... within 93 genes including ... more than 80 tyrosine ... were developed and validated ...
... Mouse anti-Yersinia pestis F1 antigen, ... Applications: ELISA: Use at ... at an assay dependent dilution. WB: ... Predicted molecular weight: 18 kDa. Not ...
... Fixation medium Reagent B - Permeabilisation medium ... cells in suspension with Reagent A and ... This procedure gives antibodies access to intracellular ... of the cells intact. Specific formulations reduce ...
Biology Products: